新型冠状病毒肺炎相关性急性胰腺炎:证据,挑战与思考

Acute pancreatitis related to COVID-19:evidence,challenge and reflection

由新型冠状病毒(SARS-CoV-2)感染引起的新型冠状病毒肺炎(COVID-19)自2019年12月发病以来,现已全球大流行。COVID-19除影响呼吸系统外,还可造成全身多系统、多脏器的损害。目前关于COVID-19累及胰腺的证据十分有限,COVID-19患者中急性胰腺炎(AP)的发病率存在不确定性,其临床特征和发病机制也存在诸多疑问。在全球COVID-19流行仍未得到完全控制的背景下,由于目前对COVID-19与AP之间相互作用知之甚少,我们必须警惕他们之间可能存在的联系。临床上诸多治疗程序需要合理化,应采取有效的防护措施,在科学诊治患者的同时有效避免医护人员SARS-CoV-2感染。

Coronavirus disease 2019(COVID-19)caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)has led to a world-wide pandemic since its onset in December of 2019.Not only capable of cause pneumonia,COVID-19 may also damage other organs.The data about pancreatic indueced by COVID-19 was limited.The incidence,clinical course,pathogenesis and outcomes of acute pancreatitis in these patients remain uncertain.The interaction between SARS-CoV-2 and pancreas are also limited.Therefore,it is imperative for us to keep in mind the possible association between COVID-19 and acute pancreatitis.Hence,rational therapeutic procedures should performed during this pandemic.Effective protective measures should be taken to prevent SARS-CoV-2 infection among health care workers when take care these patients.